Would you rather die of liver failure or live with HIV?
This was the ethical dilemma faced by doctors at Wits Donald Gordon Medical Centre to save a child's life. In 2017, doctors from the Transplant...
NEWS INDEX
MD Anderson and Cyclacel Pharmaceuticals announce strategic alliance to study novel Cyclacel medicin
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for...
More wet and dry weather extremes projected with global warming
Credit: Bob Nichols/USDA Global warming is projected to spawn more extreme wet and dry weather around the world, according to a Rutgers-led study. Those extremes...
Robot could one day fight most common cancer in men
A robot could become the 'weapon' of choice for detecting and treating the most common cancer in men, improving results and reducing side effects. Scientists...
Researcher blocks protein that defeats powerful tumor suppressor in breast cancer
Credit: TTUHSC Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the...
First large study details cognitive outcomes among older breast cancer patients
WASHINGTON -- The first large U.S. study of cognition in older breast cancer patients found that within the first two years after diagnosis and treatment,...
BPS congratulates biophysicist Frances Arnold on her Nobel Prize
ROCKVILLE, MD - The Biophysical Society (BPS) commends Frances Arnold, California Institute of Technology, on her shared Nobel Prize in chemistry. The Royal Swedish Academy...
Arizona bioscience community honors two of TGen’s top scientists
PHOENIX, Ariz. -- Oct. 3, 2018 -- Two top scientists from the Translational Genomics Research Institute (TGen), an affiliate of the City of Hope, will...
A novel molecule could spur new class of drugs for breast cancer
Credit: Stevens Institute of Technology Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a...
T cell bispecific antibody for the immune-mediated killing of HER2+ breast cancer cells
(Vall d'Hebron Institute of Oncology) Researchers at the Vall d'Hebron Institute of Oncology in Barcelona show that the p95HER2-T cell bispecific antibody (TCB) can successfully...
Recording device for cell history
Different "events" such as infections by viruses, as well as the exposure to environmental toxins or other forms of stress, change the activity of genes...
MSU faculty awarded $1 million grant to research tree chemistry in bark beetle battle
Credit: MSU Photo by Adrian Sanchez-Gonzalez BOZEMAN - As bark beetles continue to devour sickly pine forests, a Montana State University plant physiologist and ecologist...
Riffyn launches Open Access for scientists at non-profits
Credit: Riffyn Oakland, CA, USA, 3 October 2018 - Riffyn, a global provider of cloud-based experiment design and data analytics software, has launched Riffyn Open...
Proposed simple chemical reaction network of existing biological E. coli signaling data
Apparently, bacteria do not care about math and they do not have in their curricula a calculus course. Yet they are able to exhibit a...
Family of rodents may explain how some groups of animals become so diverse
TALLAHASSEE, Fla. -- How did a single species of rodent invade South America and then quickly branch off into 350 new species? The answer is...
